Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancerFelicity E. B. May|Cancer Management and Research|2014Cited by 83
TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancerFelicity E. B. May, Bruce R. Westley|Endocrine Related Cancer|2015Cited by 56
Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathwayBrendan C. Luey, Felicity E. B. May|Molecular Cancer|2016Cited by 55
Insulin and the insulin receptor collaborate to promote human gastric cancerMarina Saisana, Felicity E. B. May|Gastric Cancer|2021Cited by 22
Importance of the type I insulin-like growth factor receptor in<i>HER2, FGFR2</i>and<i>MET</i>-unamplified gastric cancer with and without Ras pathway activationMarina Saisana, Felicity E. B. May|Oncotarget|2016Cited by 16